Stocks and Investing
Stocks and Investing
Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Nierengarten Reiterated (TCRX) at Buy and Held Target at $10 on, Aug 13th, 2024
David Nierengarten of Wedbush, Reiterated "TScan Therapeutics, Inc." (TCRX) at Buy and Held Target at $10 on, Aug 13th, 2024.
David has made no other calls on TCRX in the last 4 months.
There are 2 other peers that have a rating on TCRX. Out of the 2 peers that are also analyzing TCRX, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $11 on, Monday, August 12th, 2024
- Justin Zelin of "BTIG" Initiated at Strong Buy and Held Target at $12 on, Thursday, May 16th, 2024
Contributing Sources